Thursday, May 24th 08:16 PM IST

 

M2M with Ravi Ananthanarayanan
Ranbaxy Laboratories should have seen its shares soar with its launch of a generic version of the drug Lipitor in the US. So why are investors not enthused?
 Ranbaxy Laboratories Videos.
RELATED TO.
Lipitor

Lipitor

DRUG
Pfizer Inc.

Pfizer Inc.

ORGANIZATION
Daiichi Sankyo

Daiichi Sankyo

ORGANIZATION